Jazz Pharmaceuticals (JAZZ) Insider Trading & Ownership $105.45 +2.54 (+2.47%) As of 11:24 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Jazz Pharmaceuticals (NASDAQ:JAZZ) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage4.20%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)$9.99 MNumber OfInsiders Selling(Last 12 Months)5Amount OfInsider Selling(Last 12 Months)$5.31 M Get JAZZ Insider Trade Alerts Want to know when executives and insiders are buying or selling Jazz Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address JAZZ Insider Buying and Selling by Quarter Jazz Pharmaceuticals Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails5/12/2025Seamus MulliganDirectorBuy1,621$103.00$166,963.00 5/9/2025Seamus MulliganDirectorBuy100,000$98.26$9,826,000.00 5/1/2025Bruce C CozaddCEOSell1,000$116.35$116,350.00 4/1/2025Bruce C CozaddCEOSell1,500$123.75$185,625.00 3/10/2025Patricia CarrCAOSell1,140$137.81$157,103.40 3/10/2025Robert IannoneCMOSell2,403$138.41$332,599.23 3/7/2025Robert IannoneCMOSell7,080$138.60$981,288.00 3/3/2025Bruce C CozaddCEOSell6,500$144.25$937,625.00 2/27/2025Neena M PatilEVPSell3,800$144.87$550,506.00 2/27/2025Patricia CarrCAOSell4,813$144.42$695,093.46 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 2/3/2025Bruce C CozaddCEOSell1,500$122.31$183,465.00 1/2/2025Bruce C CozaddCEOSell1,500$123.43$185,145.00 12/2/2024Bruce C CozaddCEOSell2,000$121.17$242,340.00 12/2/2024Patricia CarrCAOSell53$122.49$6,491.97 11/8/2024Neena M PatilEVPSell3,700$123.41$456,617.00 11/1/2024Bruce C CozaddCEOSell1,000$110.84$110,840.00 9/6/2024Mary Elizabeth HendersonSVPSell1,410$108.30$152,703.00 6/7/2024Patricia CarrCAOSell163$108.83$17,739.29 (Data available from 1/1/2013 forward) JAZZ Insider Trading Activity - Frequently Asked Questions Who is on Jazz Pharmaceuticals's Insider Roster? The list of insiders at Jazz Pharmaceuticals includes Bruce C Cozadd, Christopher J Tovey, Finbar Larkin, Jennifer E Cook, Kenneth W O'keefe, Kim Sablich, Mark Douglas Smith, Mary Elizabeth Henderson, Neena M Patil, Patricia Carr, Patrick G Enright, Peter Gray, Philip L Johnson, Renee D Gala, Rick E Winningham, Robert Iannone, Samantha Pearce, and Seamus Mulligan. Learn more on insiders at JAZZ. What percentage of Jazz Pharmaceuticals stock is owned by insiders? 4.20% of Jazz Pharmaceuticals stock is owned by insiders. Learn more on JAZZ's insider holdings. Which Jazz Pharmaceuticals insiders have been buying company stock? The following insiders have purchased JAZZ shares in the last 24 months: Philip L Johnson ($1,435,800.00), and Seamus Mulligan ($9,992,963.00). How much insider buying is happening at Jazz Pharmaceuticals? Insiders have purchased a total of 113,621 JAZZ shares in the last 24 months for a total of $11,428,763.00 bought. Which Jazz Pharmaceuticals insiders have been selling company stock? The following insiders have sold JAZZ shares in the last 24 months: Bruce C Cozadd ($1,961,390.00), Mark Douglas Smith ($49,735.59), Mary Elizabeth Henderson ($152,703.00), Neena M Patil ($2,081,208.50), Patricia Carr ($1,166,371.10), Renee D Gala ($790,500.00), Rick E Winningham ($171,456.56), and Robert Iannone ($1,313,887.23). How much insider selling is happening at Jazz Pharmaceuticals? Insiders have sold a total of 58,432 Jazz Pharmaceuticals shares in the last 24 months for a total of $7,687,251.98 sold. Jazz Pharmaceuticals Key ExecutivesMr. Bruce C. Cozadd (Age 60)Co-Founder, Chairman & CEO Compensation: $2.44M6 recent tradesMs. Renee D. Gala (Age 52)President & COO Compensation: $1.36MMs. Patricia Carr (Age 53)Senior VP & Chief Accounting Officer Compensation: $633.4k3 recent tradesMs. Neena M. Patil J.D. (Age 49)Executive VP & Chief Legal Officer Compensation: $1.01M1 recent tradesDr. Robert Iannone M.D. (Age 57)Executive VP, Chief Medical Officer and Global Head of Research & Development Compensation: $1.19MMr. Philip L. Johnson (Age 60)Executive VP & CFO Ms. Andrea N. Flynn Ph.D.VP & Head of Investor RelationsMs. Heidi Manna (Age 53)Executive VP & Chief People Officer Dr. Jed Black M.D.Senior Vice President of Sleep & CNS MedicineMs. Samantha Pearce (Age 58)Executive VP & Chief Commercial OfficerChief Commercial Officer More Insider Trading Tools from MarketBeat Related Companies Royalty Pharma Insider Transactions Corcept Therapeutics Insider Transactions Perrigo Insider Transactions Supernus Pharmaceuticals Insider Transactions Pacira BioSciences Insider Transactions Omeros Insider Transactions Nektar Therapeutics Insider Transactions Assembly Biosciences Insider Transactions Cumberland Pharmaceuticals Insider Transactions Eli Lilly and Company Insider Transactions Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles The Top-Ranked Insider Buys From April by Market CapMcDonald’s Insiders Sell Shares! Investors Should Do the Opposite5 Mid-Cap Stocks Insiders Are Buying This YearInsider Buying in This Stock Reiterates Analysts Bullish OutlookBeware of BigBear.ai: Insiders Are Selling—Should You? This page (NASDAQ:JAZZ) was last updated on 5/14/2025 by MarketBeat.com Staff From Our PartnersThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredSilver’s 332% Surge?Silver has quietly become one of the most promising investments of this cycle. Russia is now stockpiling silve...Lear Capital | SponsoredWatch This Robotics Demo Before July 23rdJeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%... ...Brownstone Research | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredTrump Quietly Planning $15 Trillion Crypto ShockerMost investors are still unaware, but I believe a new White House action may have quietly opened the floodgate...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Jazz Pharmaceuticals plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Jazz Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.